B
Beijing Qingpu Technology
A high-tech enterprise that provides real-time, accurate, and simple detection solutions for field testing
About Beijing Qingpu Technology
Beijing Qingpu Technology Co., Ltd. (also known as PURSPEC) is a high-tech enterprise specializing in the development and manufacturing of advanced mass spectrometry analytical products. The company was founded in December 2014 by Professor Zheng Ouyang, a renowned expert in mass spectrometry who holds professorships at both Tsinghua University and Purdue University. Professor Ouyang, an advocate for the miniaturization of mass spectrometers, earned his Ph.D. in analytical chemistry from Purdue University and has an extensive background in mass spectrometer theory, instrument design, and ionization techniques. His vision to translate academic research into practical applications forms the foundation of the company, which leverages over a decade of research accumulated across five generations of mass spectrometry instruments.
The firm operates at the intersection of scientific research and commercial application, focusing on providing real-time, accurate, and user-friendly detection solutions for on-site analysis. Its business model centers on the research, development, production, and service of high-end mass spectrometry equipment. The company serves a diverse client base across sectors such as public security, biopharmaceuticals, clinical diagnostics, food safety, and environmental monitoring. Revenue is generated through the sale of its proprietary instruments and analytical systems, as well as providing customized solutions to over 100 clients in academia, healthcare, and security.
Qingpu Technology has commercialized a range of products, including miniaturized mass spectrometers and advanced structural lipidomics solutions. A key product is the 'Cell' miniature mass spectrometer, designed for portability and intelligent, one-click operation. Another significant offering is the 'ΩAnalyzer' system, which provides in-depth lipid structural analysis for applications in biomedical research and nutrition studies. The company's innovations have earned accolades, such as the "BCEIA Gold Award" in 2017 for its Mini β small mass spectrometry analysis system. Supported by deep collaborations with Tsinghua University and Purdue University, the company has established over 60 core patents and continues to advance its technology, recently securing nearly 100 million RMB in a Series A+ funding round in May 2024 to fuel further product development and international expansion.
Source: Dealroom company dataKnowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES A✓Equity / VC | May 2024 | $14M | $55M | Qingkong Jinxin Capital | ↗ |
| OtherOther financing | Jan 2014 | $0 | — | Shuimu Venture Capital | ↗ |
Growth signals
Latest recorded traffic for Beijing Qingpu Technology is 240 monthly website visits, down 84% over the last three months. Beijing Qingpu Technology's team grew 0% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A1 investor entered at this stage
- QCQingkong Jinxin Capital
Other known investors1 additional known investor
Shuimu Venture Capital
Source: Dealroom Talent Intelligence.
Global footprint
Market sentiment
An AI-synthesised read of the highest-engagement posts about Beijing Qingpu Technology on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See Beijing Qingpu Technology’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.







